Islamization: El-Rufai seeking relevance, ignore him – CAN

The Chairman of Kaduna State Christian Association of Nigeria, Reverend Joseph Hayab, on Wednesday, urged Nigerians to ignore the state’s immediate past governor, Nasir El-Rufai, over the latter’s alleged Islamization claims. He also claimed that the ex-governor’s recent statement on the Muslim/Muslim ticket and that the victory of President Bola Tinubu silenced his critics and…

Read More

JUST IN: President Tinubu swears in new SGF, George Akume

Senator George Akume has assumed his role as the new Secretary to Government of the Federation (SGF) following his swearing-in on Wednesday morning by President Bola Tinubu. The President administered the oath of office on him in the Council Chamber of the Presidential Villa, Abuja witnessed by the SGF’s wife, Regina; Vice President Kashim Shettima;…

Read More

(OPINION) The Osun Startup Ecosystem: Efforts, Reality, Missing Gaps, by Adisa Kabiru Adeniyi

The Osun state in Nigeria has made significant strides in developing its startup ecosystem in recent years. With a growing population, vibrant youth demographic, and government support, the region has become an attractive destination for entrepreneurs and innovators. However, while there have been commendable efforts to foster a conducive environment for startups, there are still…

Read More

Billionaire Business Mogul,Jimoh Ibrahim Explains How Nigeria Can Repay Debts Within 90 Days

The Ondo-born businessman also spoke about Nigeria’s security challenges, especially the Boko Haram insurgency that has ravaged the nation for over a decade. Senator-elect and billionaire business mogul, Dr Jimoh Ibrahim, has proposed a plan for Nigeria to repay its debts within 90 days. Speaking during an interview on Channels Television’s Politics Today, Ibrahim said…

Read More

EU approves first vaccine for common respiratory virus

The European Commission has followed the United States in approving the world’s first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday. “This authorisation for Arexvy means eligible adults can be vaccinated against RSV disease for the first time,” GSK’s chief scientific officer Tony…

Read More